Muhammad Saddiq Zahari
Johns Hopkins University(US)Johns Hopkins Bayview Medical Center(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, HER2/EGFR in Cancer Research, Cancer Cells and Metastasis, Monoclonal and Polyclonal Antibodies Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → A draft map of the human proteome(2014)2,281 cited
- → Activation of diverse signalling pathways by oncogenic PIK3CA mutations(2014)83 cited
- → Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways(2015)67 cited
- → The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer(2016)59 cited
- → Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer(2015)56 cited
- → A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers(2014)20 cited
- → Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts(2018)18 cited
- → A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations(2014)14 cited
- → Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia(2015)12 cited
- → Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome(2015)11 cited